Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd M Brusko

Showing results (21-30 of 140) with videos related to

Pageof 14
Sort By:
Nature Reviews. Immunology|February 2, 2024
The immunology of type 1 diabetesKevan C Herold, Thomas Delong, Ana Luisa Perdigoto, et al.
Diabetes|September 8, 2017
Type 1 Interferons Potentiate Human CD8<sup>+</sup> T-Cell Cytotoxicity Through a STAT4- and Granzyme B-Dependent PathwayBrittney N Newby, Todd M Brusko, Baiming Zou, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2025
Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific StatementAaron W Michels, Todd M Brusko, Carmella Evans-Molina, et al.
Science Advances|November 7, 2025
Human stem cell-derived β cells expressing an optimized CD155 reduce cytotoxic immune cell function for application in type 1 diabetesMatthew E Brown, Jessie M Barra, Marcus R Pina, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Human Stem Cell-Derived β-cells Expressing An Optimized CD155 Reduce Cytotoxic Immune Cell Function for Application in Type 1 DiabetesMatthew E Brown, Jessie M Barra, Marcus R Pina, et al.
Diabetologia|December 18, 2024
Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetesMelanie R Shapiro, Erin M Tallon, Matthew E Brown, et al.
Current Diabetes Reports|September 1, 2018
Immune Mechanisms and Pathways Targeted in Type 1 DiabetesLaura M Jacobsen, Brittney N Newby, Daniel J Perry, et al.
Science Advances|June 2, 2023
Immune engineered extracellular vesicles to modulate T cell activation in the context of type 1 diabetesMatthew W Becker, Leeana D Peters, Thinzar Myint, et al.
Frontiers in Immunology|May 17, 2024
A global view of T cell metabolism in systemic lupus erythematosusAndrew Goetz, Joy Cagmat, Maigan Brusko, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2021
CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIIIJyoti Rana, Daniel J Perry, Sandeep R P Kumar, et al.
Pageof 14

Showing results (21-30 of 140) with videos related to

Sort By:
Pageof 14
Nature Reviews. Immunology|February 2, 2024
The immunology of type 1 diabetesKevan C Herold, Thomas Delong, Ana Luisa Perdigoto, et al.
Diabetes|September 8, 2017
Type 1 Interferons Potentiate Human CD8<sup>+</sup> T-Cell Cytotoxicity Through a STAT4- and Granzyme B-Dependent PathwayBrittney N Newby, Todd M Brusko, Baiming Zou, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2025
Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific StatementAaron W Michels, Todd M Brusko, Carmella Evans-Molina, et al.
Science Advances|November 7, 2025
Human stem cell-derived β cells expressing an optimized CD155 reduce cytotoxic immune cell function for application in type 1 diabetesMatthew E Brown, Jessie M Barra, Marcus R Pina, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Human Stem Cell-Derived β-cells Expressing An Optimized CD155 Reduce Cytotoxic Immune Cell Function for Application in Type 1 DiabetesMatthew E Brown, Jessie M Barra, Marcus R Pina, et al.
Diabetologia|December 18, 2024
Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetesMelanie R Shapiro, Erin M Tallon, Matthew E Brown, et al.
Current Diabetes Reports|September 1, 2018
Immune Mechanisms and Pathways Targeted in Type 1 DiabetesLaura M Jacobsen, Brittney N Newby, Daniel J Perry, et al.
Science Advances|June 2, 2023
Immune engineered extracellular vesicles to modulate T cell activation in the context of type 1 diabetesMatthew W Becker, Leeana D Peters, Thinzar Myint, et al.
Frontiers in Immunology|May 17, 2024
A global view of T cell metabolism in systemic lupus erythematosusAndrew Goetz, Joy Cagmat, Maigan Brusko, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2021
CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIIIJyoti Rana, Daniel J Perry, Sandeep R P Kumar, et al.
Pageof 14